Skip to content
Screener

Bio-Rad Laboratories BIO Life Science — Goodwill

Other segment segments

Clinical Diagnostics
$421.8M+1.3%

Similar metrics at other companies

Danaher logo
DHRLife Sciences — Goodwill
$12.78B-0.8%
Revvity logo
RVTYLife Sciences — Goodwill
$4.75B+3.9%
Ashland logo
ASHLife Sciences — Goodwill
$462M-0.9%
Donaldson Company logo
DCILife Sciences Segment — Goodwill
$172.8M+2.2%
Thermo Fisher Scientific logo
TMOLife Sciences Solutions — Goodwill
$14.91B+20.9%
Clarivate logo
CLVTLife Sciences & Healthcare — Goodwill
$256.1M—

Other financials

Income statement

See full
Revenue$592.1M+1.1%
Gross profit$309.4M+1.1%
Operating income$34.1M+43.9%
Net income-$527.1M-924%
EPS (diluted)-$19.55-954%

Balance sheet

See full
Cash & equivalents$509.0M-2.7%
Total debt$987.3M-28.4%
Total equity$6.9B+2.6%
Total assets$9.8B+2.8%

Cash flow

See full
Operating cash flow$108.1M-16.8%
CapEx$30.0M-12.8%
Free cash flow$78.1M-18.2%

Valuation

See full
Market cap$9.3B+30.0%
Enterprise value$9.78B+19.3%
P/E55.1×+32.7×
P/S3.6×+0.8×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin8.8%-3.1pp
Net margin6.5%+3.4pp
FCF margin13.8%-0.2pp

Returns & leverage

See full
Return on equity2.5%+1.3pp
Debt / equity0.1×-0.1×
Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories in its filing.

Tagged under the XBRL concept us-gaap:GoodwillGross.

The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:19 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000012208-26-000035
Balances as of December 31, 2025Life ScienceClinical DiagnosticsTotal
Accumulated impairment losses(41.8)(293.4)(335.2)
Goodwill, net451.4128.4579.8
Foreign currency adjustments(2.7)—(2.7)
Period change, net(2.7)—(2.7)
Balances as of March 31, 2026
Goodwill490.5421.8912.3
Accumulated impairment losses(41.8)(293.4)(335.2)
Goodwill, net$448.7$128.4$577.1

Item 1. Financial Statements (Unaudited)

FAQ

What is Bio-Rad Laboratories's life science — goodwill?
Bio-Rad Laboratories (BIO) reported life science — goodwill of $490.5M in Q1 2026.
How has Bio-Rad Laboratories's life science — goodwill changed year-over-year?
Bio-Rad Laboratories's life science — goodwill increased by 47.2% year-over-year, from $333.3M to $490.5M.
What is the long-term trend for Bio-Rad Laboratories's life science — goodwill?
Over 4 years (2021 to 2025), Bio-Rad Laboratories's life science — goodwill has grown at a 11.7% compound annual growth rate (CAGR), from $1.17B to $1.81B.
What does life science — goodwill mean?
Represents the total carrying value of goodwill associated with the Life Science business segment. This asset arises when the company acquires another business for a price exceeding the fair value of its identifiable net assets, reflecting the premium paid for intangible synergies and market position.

Ask your AI about Bio-Rad Laboratories's life science — goodwill.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude